AR050838A1 - Formulacion farmaceutica. para el tratamiento de una infeccion optica - Google Patents
Formulacion farmaceutica. para el tratamiento de una infeccion opticaInfo
- Publication number
- AR050838A1 AR050838A1 ARP050103355A ARP050103355A AR050838A1 AR 050838 A1 AR050838 A1 AR 050838A1 AR P050103355 A ARP050103355 A AR P050103355A AR P050103355 A ARP050103355 A AR P050103355A AR 050838 A1 AR050838 A1 AR 050838A1
- Authority
- AR
- Argentina
- Prior art keywords
- optical
- treatment
- infection
- pharmaceutically acceptable
- pharmaceutical formulation
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 230000003287 optical effect Effects 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000000843 anti-fungal effect Effects 0.000 abstract 2
- 229940121375 antifungal agent Drugs 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229960004123 mometasone furoate monohydrate Drugs 0.000 abstract 2
- QIPQASLPWJVQMH-DTORHVGOSA-N Orbifloxacin Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=C(F)C(F)=C2C(=O)C(C(O)=O)=CN(C3CC3)C2=C1F QIPQASLPWJVQMH-DTORHVGOSA-N 0.000 abstract 1
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003246 corticosteroid Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 229960004780 orbifloxacin Drugs 0.000 abstract 1
- 239000003306 quinoline derived antiinfective agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- -1 triazole compound Chemical class 0.000 abstract 1
- 150000003852 triazoles Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60147504P | 2004-08-13 | 2004-08-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR050838A1 true AR050838A1 (es) | 2006-11-29 |
Family
ID=35431350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050103355A AR050838A1 (es) | 2004-08-13 | 2005-08-11 | Formulacion farmaceutica. para el tratamiento de una infeccion optica |
Country Status (28)
Country | Link |
---|---|
US (2) | US8084445B2 (fr) |
EP (1) | EP1776109B1 (fr) |
JP (2) | JP4792032B2 (fr) |
KR (1) | KR101289115B1 (fr) |
CN (2) | CN102499928A (fr) |
AR (1) | AR050838A1 (fr) |
AT (1) | ATE418984T1 (fr) |
AU (1) | AU2005272925B2 (fr) |
BR (1) | BRPI0514098B1 (fr) |
CA (1) | CA2576589C (fr) |
DE (1) | DE602005012107D1 (fr) |
DK (1) | DK1776109T3 (fr) |
EC (1) | ECSP077239A (fr) |
ES (1) | ES2320360T3 (fr) |
HK (1) | HK1098368A1 (fr) |
IL (1) | IL181248A (fr) |
MX (1) | MX2007001811A (fr) |
MY (1) | MY145148A (fr) |
NO (1) | NO20073073L (fr) |
NZ (1) | NZ553119A (fr) |
PE (1) | PE20060489A1 (fr) |
PL (1) | PL1776109T3 (fr) |
PT (1) | PT1776109E (fr) |
RU (1) | RU2394573C2 (fr) |
TW (1) | TWI362261B (fr) |
UA (1) | UA89793C2 (fr) |
WO (1) | WO2006020689A1 (fr) |
ZA (1) | ZA200701253B (fr) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE518540T1 (de) * | 1999-08-16 | 2011-08-15 | Revaax Pharmaceuticals Llc | Beta-lactam verbindung enthaltende neurotherapeutische zusammensetzung |
US6426342B2 (en) * | 1999-08-16 | 2002-07-30 | Revaax Pharmaceuticals, Llc | Use of β-lactamase inhibitors as neuroprotectants |
US8088820B2 (en) * | 2001-04-24 | 2012-01-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for the treatment of malaria |
PE20060489A1 (es) | 2004-08-13 | 2006-06-19 | Schering Plough Ltd | Formulacion farmaceutica que comprende un antibiotico, un triazol y un corticosteroide |
DE102005055385A1 (de) * | 2004-12-09 | 2006-06-14 | Bayer Healthcare Ag | Arzneimittel zur hygienischen Applikation im Ohr |
DE102006010642A1 (de) * | 2006-03-08 | 2007-09-27 | Bayer Healthcare Aktiengesellschaft | Arzneimittelformulierungen, enthaltend Fluorchinolone |
DE102006010643A1 (de) * | 2006-03-08 | 2007-09-13 | Bayer Healthcare Aktiengesellschaft | Arzneimittel enthaltend Fluorchinolone |
US20090275552A1 (en) * | 2006-04-28 | 2009-11-05 | Mahesh Vithalbhai Patel | Therapy for Treating Resistant Bacterial Infections |
WO2008002118A1 (fr) * | 2006-06-27 | 2008-01-03 | Arturo Jimenez Bayardo | Formulation ophtalmique en suspension d'étabonate de loteprednol et de chlorhydrate de ciprofloxacine |
BRPI0703127A2 (pt) * | 2007-08-22 | 2009-04-14 | Ouro Fino Participacoes E Empreendimentos Sa | composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia |
JP2011500811A (ja) * | 2007-10-26 | 2011-01-06 | レクサン ファーマシューティカルズ インコーポレイテッド | クラブラン酸の医薬品製剤 |
PE20091171A1 (es) * | 2007-12-14 | 2009-08-03 | Schering Plough Ltd | Proceso para recuperar florfenicol y analogos de florfenicol |
TW201010708A (en) * | 2008-06-02 | 2010-03-16 | Intervet Int Bv | Composition comprising an antibiotic and a corticosteroid |
US8318817B2 (en) * | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
MX2011011459A (es) * | 2009-04-29 | 2011-11-18 | Rexahn Pharmaceuticals Inc | Formulacion de clavulanato para neuroproteccion y tratamiento de trastornos neurodegenerativos. |
ES2893444T3 (es) * | 2010-06-29 | 2022-02-09 | Merck Sharp & Dohme | Formulaciones de posaconazol en solución intravenosa estabilizadas mediante beta-ciclodextrina sustituida |
US9320690B2 (en) | 2010-12-20 | 2016-04-26 | Colgate-Palmolive Company | Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier |
MX350659B (es) * | 2011-11-30 | 2017-09-13 | Toyama Chemical Co Ltd | Tableta que contiene hidrato de metansulfonato del acido 1-ciclopropil- 8 - (difluorometoxi) -7- [ (1r) -1-metil-2,3-dihidro-1h-isoindol-5-il] -4-oxo-1,4-dihidroquinolin- 3-carboxilico. |
BR112015016033A8 (pt) * | 2013-01-14 | 2018-01-23 | Wockhardt Ltd | composições farmacêuticas para tratamento de infecções por bactérias, e seus usos |
KR101473979B1 (ko) * | 2013-01-18 | 2014-12-26 | 한국썸벧(주) | 마보플록사신을 포함하는 약제학적 조성물 |
US9078853B2 (en) | 2013-06-18 | 2015-07-14 | Cmpd Licensing, Llc | Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders |
CN104606141A (zh) * | 2013-11-01 | 2015-05-13 | 瑞普(天津)生物药业有限公司 | 一种替米考星肠溶微丸 |
CN104983718A (zh) * | 2015-07-17 | 2015-10-21 | 江西博莱大药厂有限公司 | 一种替米考星缓释微丸及其制备方法和应用 |
CN105412123B (zh) * | 2015-11-06 | 2018-03-13 | 山东省千佛山医院 | 布地奈德联合三唑类抗真菌药物的应用及其产品 |
WO2017091168A1 (fr) | 2015-11-28 | 2017-06-01 | Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. | Pulvérisation topique comprenant du nitrate d'isoconazole et du valérate de difluocortolone |
US10525025B2 (en) | 2016-11-17 | 2020-01-07 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
US11986448B2 (en) | 2016-11-17 | 2024-05-21 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
US11737975B2 (en) | 2016-11-17 | 2023-08-29 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
US10966946B2 (en) | 2016-11-17 | 2021-04-06 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
US9999604B2 (en) | 2016-11-17 | 2018-06-19 | Cmpd Licensing, Llc | Compounded solutions of diclofenac and lidocaine and methods |
CN109096307A (zh) * | 2017-06-20 | 2018-12-28 | 赵建宇 | 一种33/4水头孢曲松钠化合物 |
WO2019126910A1 (fr) * | 2017-12-25 | 2019-07-04 | 湘北威尔曼制药股份有限公司 | Composition comprenant de la pipéracilline, sa préparation pharmaceutique et son utilisation |
AU2020361511A1 (en) * | 2019-10-11 | 2022-04-14 | Dechra Veterinary Products, Llc | Otic formulations, methods and devices |
CN111166719A (zh) * | 2019-12-31 | 2020-05-19 | 郑州都灵兽药科技有限公司 | 一种泰拉霉素肠溶颗粒的制备方法 |
CN112089695A (zh) * | 2020-10-30 | 2020-12-18 | 康普药业股份有限公司 | 一种头孢克肟颗粒制剂及其制备方法 |
AU2022421489A1 (en) | 2021-12-20 | 2024-06-06 | Intervet International B.V. | A pharmaceutical composition for the treatment of otic infections |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4141078A (en) | 1975-10-14 | 1979-02-20 | Innovated Systems, Inc. | Library circulation control system |
US4235892A (en) * | 1979-02-05 | 1980-11-25 | Schering Corporation, Patent Dept. | 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor |
ES8104203A1 (es) * | 1979-02-05 | 1981-04-16 | Schering Corp | Un procedimiento para la preparacion de un compuesto d-(treo-1-aril-2-acilamido-3-fluor-1-propanol |
US4458802A (en) | 1981-03-03 | 1984-07-10 | K.J.A. Maciver & Sons (Proprietary) Limited | Renting of articles and machine thereof |
US4820695A (en) * | 1982-09-13 | 1989-04-11 | Eli Lilly And Company | C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics |
US4443430A (en) * | 1982-11-16 | 1984-04-17 | Ethicon, Inc. | Synthetic absorbable hemostatic agent |
US5105009A (en) * | 1983-06-02 | 1992-04-14 | Zambon S.P.A. | Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives |
IT1173213B (it) * | 1984-02-03 | 1987-06-18 | Zambon Spa | Procedimento per fluorurare alcuni derivati dall'1l-fenil-2-ammino-1,3-propandiolo e loro intermedi |
US5332835A (en) * | 1984-02-03 | 1994-07-26 | Zambon S.P.A. | Process for fluorinating 1-phenyl-2-amino-1,3-propanediol compounds and new oxazoline compounds useful in this process |
US4973750A (en) * | 1984-09-19 | 1990-11-27 | Schering Corporation | Preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols |
US4582918A (en) * | 1984-09-19 | 1986-04-15 | Schering Corporation | Preparation of intermediates for (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols |
US4812629A (en) | 1985-03-06 | 1989-03-14 | Term-Tronics, Incorporated | Method and apparatus for vending |
US5104868A (en) * | 1988-06-21 | 1992-04-14 | Pfizer Inc. | Tricyclic derivatives of 7-substituted-6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acids and esters |
US5095195A (en) | 1988-08-03 | 1992-03-10 | Thru-The-Wall Corporation | Automated videocassette dispensing terminal with reservation feature |
US5594228A (en) | 1988-08-25 | 1997-01-14 | Symbol Technologies, Inc. | Self-checkout, point-of-transaction system including deactivatable electro-optically coded surveillance tags |
US5227494A (en) * | 1988-09-14 | 1993-07-13 | Schering Corporation | Process for preparing oxazoline compounds |
US4876352A (en) * | 1988-09-14 | 1989-10-24 | Schering Corporation | Pressurized fluorination of hydroxy alkyl groups |
US5491139A (en) * | 1988-10-24 | 1996-02-13 | The Procter & Gamble Company | Antimicrobial quinolonyl lactams |
CA2001203C (fr) * | 1988-10-24 | 2001-02-13 | Thomas P. Demuth, Jr. | Dithiocarbamoyl quinolones antimicrobiens |
US5007518A (en) | 1989-02-13 | 1991-04-16 | Sam Crivello | Apparatus for renting articles |
US5198220A (en) * | 1989-11-17 | 1993-03-30 | The Procter & Gamble Company | Sustained release compositions for treating periodontal disease |
AU640481B2 (en) * | 1990-04-18 | 1993-08-26 | Norwich Eaton Pharmaceuticals, Inc. | Penicillan or cephalosporin derivatives of quinolonyl |
PL166385B1 (en) * | 1990-10-25 | 1995-05-31 | Schering Corp | Method of obtaining oxazoline compound |
US5242910A (en) * | 1992-10-13 | 1993-09-07 | The Procter & Gamble Company | Sustained release compositions for treating periodontal disease |
US5646163A (en) * | 1992-10-30 | 1997-07-08 | The Procter & Gamble Company | Quinolone 5-(N-heterosubstituted amino) antimicrobials |
US5352832A (en) * | 1992-12-18 | 1994-10-04 | Schering Corporation | Asymmetric process for preparing florfenicol, thiamphenicol chloramphenicol and oxazoline intermediates |
KR0148277B1 (ko) * | 1993-01-18 | 1998-11-02 | 채영복 | 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법 |
WO1994025464A1 (fr) * | 1993-04-24 | 1994-11-10 | Korea Research Institute Of Chemical Technology | Nouveaux derives d'acide quinolone-carboxylique et leur procede de preparation |
HU216803B (hu) * | 1993-08-13 | 1999-08-30 | Dong Wha Pharmaceutical Industrial Co., Ltd. | Új kinolon-karbonsav-származékok |
FR2711524B1 (fr) * | 1993-10-21 | 1995-11-24 | Rhone Dpc Europ | Procédé de préparation de compositions orales contenant des quinolones. |
WO1995012870A1 (fr) | 1993-11-04 | 1995-05-11 | Knogo Corporation | Procede et appareil de desensibilisation automatique d'elements detecteurs |
US5661151A (en) * | 1993-12-21 | 1997-08-26 | Schering Corporation | Tetrahydrofuran antifungals |
PT736030E (pt) * | 1993-12-21 | 2002-01-30 | Schering Corp | Antifungicos de tetra-hidrofurano |
HUT77946A (hu) | 1994-11-18 | 1998-12-28 | Pharmacia & Upjohn Co. | Fluor-kinolon-származék fizikailag stabil, szilárd formája |
US5777884A (en) | 1995-10-16 | 1998-07-07 | Minnesota Mining And Manufacturing Company | Article inventory tracking and control system |
US5834472A (en) * | 1996-05-24 | 1998-11-10 | Schering Corporation | Antifungal composition with enhanced bioavailability |
US5846971A (en) * | 1996-06-28 | 1998-12-08 | Schering Corporation | Oral antifungal composition |
US5663361A (en) * | 1996-08-19 | 1997-09-02 | Schering Corporation | Process for preparing intermediates to florfenicol |
US5990794A (en) * | 1996-09-26 | 1999-11-23 | Sensormatic Electronics Corporation | Apparatus for data communication and deactivation of electronic article surveillance tags |
JP3892085B2 (ja) | 1996-10-04 | 2007-03-14 | 東興薬品工業株式会社 | 動物用点耳クリーム剤 |
US6025780A (en) | 1997-07-25 | 2000-02-15 | Checkpoint Systems, Inc. | RFID tags which are virtually activated and/or deactivated and apparatus and methods of using same in an electronic security system |
KR20010031363A (ko) * | 1997-10-22 | 2001-04-16 | 젠스 포니카우 | 진균류에 의한 점막염을 국소 치료하기 위한 항진균제의용도 |
EP2259239B1 (fr) * | 1998-08-14 | 2012-12-12 | 3M Innovative Properties Company | Applications pour systèmes d'identification de la fréquence radio |
MY133181A (en) | 1998-09-10 | 2007-10-31 | Schering Corp | Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines |
US6169483B1 (en) | 1999-05-04 | 2001-01-02 | Sensormatic Electronics Corporation | Self-checkout/self-check-in RFID and electronics article surveillance system |
US6333692B1 (en) | 1999-07-06 | 2001-12-25 | Ats Money Systems Inc. | Security tag deactivation system |
US20020067267A1 (en) * | 2000-03-15 | 2002-06-06 | Richard Kirkham | Package identification system |
CN1137899C (zh) | 2000-03-16 | 2004-02-11 | 上海华联制药有限公司 | 17,21-酯取代的1,4-二烯-3-酮-9,11-环氧甾体化合物 |
WO2001089495A2 (fr) | 2000-05-19 | 2001-11-29 | Alcon Laboratories, Inc. | Compositions antibiotiques destinees au traitement des yeux, oreilles et nez |
AU2001277891A1 (en) * | 2000-07-26 | 2002-02-05 | Alcon Universal Ltd. | Pharmaceutical suspension compositions lacking a polymeric suspending agent |
IL158059A0 (en) * | 2001-04-27 | 2004-03-28 | Pfizer Prod Inc | Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
US20030139382A1 (en) | 2001-09-21 | 2003-07-24 | Alcon, Inc. | Method of treating middle ear infections |
CA2499897A1 (fr) | 2002-09-23 | 2004-04-01 | Schering Corporation | Traitement d'infections fongiques |
US20050159369A1 (en) | 2003-08-20 | 2005-07-21 | Qtm Llc | Method of treatment of otitis externa |
PE20060489A1 (es) | 2004-08-13 | 2006-06-19 | Schering Plough Ltd | Formulacion farmaceutica que comprende un antibiotico, un triazol y un corticosteroide |
TW201010708A (en) * | 2008-06-02 | 2010-03-16 | Intervet Int Bv | Composition comprising an antibiotic and a corticosteroid |
-
2005
- 2005-08-10 PE PE2005000927A patent/PE20060489A1/es not_active Application Discontinuation
- 2005-08-10 EP EP05786782A patent/EP1776109B1/fr active Active
- 2005-08-10 BR BRPI0514098-6A patent/BRPI0514098B1/pt active IP Right Grant
- 2005-08-10 DE DE602005012107T patent/DE602005012107D1/de active Active
- 2005-08-10 CN CN2011102914653A patent/CN102499928A/zh active Pending
- 2005-08-10 RU RU2007108875/15A patent/RU2394573C2/ru active
- 2005-08-10 MY MYPI20053727A patent/MY145148A/en unknown
- 2005-08-10 KR KR1020077003332A patent/KR101289115B1/ko not_active IP Right Cessation
- 2005-08-10 ES ES05786782T patent/ES2320360T3/es active Active
- 2005-08-10 JP JP2007525752A patent/JP4792032B2/ja active Active
- 2005-08-10 WO PCT/US2005/028379 patent/WO2006020689A1/fr active Application Filing
- 2005-08-10 US US11/201,044 patent/US8084445B2/en active Active
- 2005-08-10 PT PT05786782T patent/PT1776109E/pt unknown
- 2005-08-10 AU AU2005272925A patent/AU2005272925B2/en active Active
- 2005-08-10 NZ NZ553119A patent/NZ553119A/en not_active IP Right Cessation
- 2005-08-10 AT AT05786782T patent/ATE418984T1/de active
- 2005-08-10 CN CNA2005800351223A patent/CN101039668A/zh active Pending
- 2005-08-10 PL PL05786782T patent/PL1776109T3/pl unknown
- 2005-08-10 CA CA2576589A patent/CA2576589C/fr active Active
- 2005-08-10 DK DK05786782T patent/DK1776109T3/da active
- 2005-08-10 UA UAA200702668A patent/UA89793C2/uk unknown
- 2005-08-10 MX MX2007001811A patent/MX2007001811A/es active IP Right Grant
- 2005-08-11 TW TW094127341A patent/TWI362261B/zh not_active IP Right Cessation
- 2005-08-11 AR ARP050103355A patent/AR050838A1/es not_active Application Discontinuation
-
2007
- 2007-02-08 IL IL181248A patent/IL181248A/en not_active IP Right Cessation
- 2007-02-12 ZA ZA200701253A patent/ZA200701253B/en unknown
- 2007-02-12 EC EC2007007239A patent/ECSP077239A/es unknown
- 2007-05-07 HK HK07104854.0A patent/HK1098368A1/xx unknown
- 2007-06-15 NO NO20073073A patent/NO20073073L/no not_active Application Discontinuation
-
2011
- 2011-06-15 JP JP2011133720A patent/JP2011178811A/ja not_active Withdrawn
- 2011-11-10 US US13/293,994 patent/US8609645B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR050838A1 (es) | Formulacion farmaceutica. para el tratamiento de una infeccion optica | |
UY29562A1 (es) | Compuestos heterocíclicos de amino benzoilo, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
WO2006048747A8 (fr) | Compositions pharmaceutiques topiques contenant un compose anti-acne et un compose antibiotique | |
UY28510A1 (es) | Compuestos quimicos | |
PA8591701A1 (es) | Derivados de pirrolopirimidina | |
PA8606201A1 (es) | DERIVADOS DE PIRROLO[3,4-c) PIRAZOL ACTIVOS COMO INHIBIDORES DE QUINASA, PROCESO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN | |
UY29182A1 (es) | "derivados de bencenosulfonamidas sustituídas, composiciones que las contienen, procedimientos de preparación y aplicaciones" | |
CY1109117T1 (el) | Διαμορφωσεις enaιωphmatoς, οι οποιες περιλαμβανουν δραστικον συστατικο, επιφανειακως δρωσαν ουσια poloxamer ή meroxapol και γλυκολη, χρησις του δια την βιομηχανικην παρασκευην φαρμακου προς νοσηλειαν οφθαλμικων διαταραχων | |
BRPI0418251B8 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
DE602004024375D1 (de) | Carboxamidderivate | |
TW200700392A (en) | Novel compounds | |
DOP2002000422A (es) | Agentes antibacterianos. | |
ZA200709296B (en) | Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycolotonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders | |
CL2008001297A1 (es) | N-[(1s)-1-(5-fluoropirim idin-2-i1 )etil]-3-(5-isopropoxi-1 h-pirazol-3-il )-3h-imidazo[4,5-b]piridin-5amina o una sal farmacéuticamente aceptabie del mismo; composición farmacéutica que lo comprende; y su uso en el tratamiento del cáncer. | |
ATE386725T1 (de) | Heterocyclylverbindungen | |
AR029226A1 (es) | Tioamidas, composiciones farmaceuticas y el uso de la misma para la fabricacion de compuestos medicinales | |
EA200400086A1 (ru) | Новые производные оксазолидинонов в качестве антибактериальных агентов | |
SE0101932D0 (sv) | Pharmaceutical combinations | |
DE602004012269D1 (de) | Quervernetzte glycopeptid-cephalosporin-antibiotika | |
DE602004024393D1 (de) | Quervernetzte glycopeptid-cephalosporin-antibiotika | |
DK1434779T3 (da) | Tværbundne glycopeptid-cephalosporinantibiotika | |
AR064152A1 (es) | Derivados de quinolina antibacterianos,composiciones farmaceuticas que los contienen y metodo de preparacion. | |
AR054888A1 (es) | Derivados de quinolina como agentes antibacterianos | |
AR053688A1 (es) | Composicion farmaceurtica y su uso | |
ECSP055625A (es) | Profarmaco inhibidor de beta-lactamasa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |